Cargando…

TB Mobile: a mobile app for anti-tuberculosis molecules with known targets

BACKGROUND: An increasing number of researchers are focused on strategies for developing inhibitors of Mycobacterium tuberculosis (Mtb) as tuberculosis (TB) drugs. RESULTS: In order to learn from prior work we have collated information on molecules screened versus Mtb and their targets which has bee...

Descripción completa

Detalles Bibliográficos
Autores principales: Ekins, Sean, Clark, Alex M, Sarker, Malabika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3616884/
https://www.ncbi.nlm.nih.gov/pubmed/23497706
http://dx.doi.org/10.1186/1758-2946-5-13
_version_ 1782265181238198272
author Ekins, Sean
Clark, Alex M
Sarker, Malabika
author_facet Ekins, Sean
Clark, Alex M
Sarker, Malabika
author_sort Ekins, Sean
collection PubMed
description BACKGROUND: An increasing number of researchers are focused on strategies for developing inhibitors of Mycobacterium tuberculosis (Mtb) as tuberculosis (TB) drugs. RESULTS: In order to learn from prior work we have collated information on molecules screened versus Mtb and their targets which has been made available in the Collaborative Drug Discovery (CDD) database. This dataset contains published data on target, essentiality, links to PubMed, TBDB, TBCyc (which provides a pathway-based visualization of the entire cellular biochemical network) and human homolog information. The development of mobile cheminformatics apps could lower the barrier to drug discovery and promote collaboration. Therefore we have used this set of over 700 molecules screened versus Mtb and their targets to create a free mobile app (TB Mobile) that displays molecule structures and links to the bioinformatics data. By input of a molecular structures and performing a similarity search within the app we can infer potential targets or search by targets to retrieve compounds known to be active. CONCLUSIONS: TB Mobile may assist researchers as part of their workflow in identifying potential targets for hits generated from phenotypic screening and in prioritizing them for further follow-up. The app is designed to lower the barriers to accessing this information, so that all researchers with an interest in combatting this deadly disease can use it freely to the benefit of their own efforts.
format Online
Article
Text
id pubmed-3616884
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-36168842013-04-05 TB Mobile: a mobile app for anti-tuberculosis molecules with known targets Ekins, Sean Clark, Alex M Sarker, Malabika J Cheminform Research Article BACKGROUND: An increasing number of researchers are focused on strategies for developing inhibitors of Mycobacterium tuberculosis (Mtb) as tuberculosis (TB) drugs. RESULTS: In order to learn from prior work we have collated information on molecules screened versus Mtb and their targets which has been made available in the Collaborative Drug Discovery (CDD) database. This dataset contains published data on target, essentiality, links to PubMed, TBDB, TBCyc (which provides a pathway-based visualization of the entire cellular biochemical network) and human homolog information. The development of mobile cheminformatics apps could lower the barrier to drug discovery and promote collaboration. Therefore we have used this set of over 700 molecules screened versus Mtb and their targets to create a free mobile app (TB Mobile) that displays molecule structures and links to the bioinformatics data. By input of a molecular structures and performing a similarity search within the app we can infer potential targets or search by targets to retrieve compounds known to be active. CONCLUSIONS: TB Mobile may assist researchers as part of their workflow in identifying potential targets for hits generated from phenotypic screening and in prioritizing them for further follow-up. The app is designed to lower the barriers to accessing this information, so that all researchers with an interest in combatting this deadly disease can use it freely to the benefit of their own efforts. BioMed Central 2013-03-06 /pmc/articles/PMC3616884/ /pubmed/23497706 http://dx.doi.org/10.1186/1758-2946-5-13 Text en Copyright © 2013 Ekins et al.; licensee Chemistry Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Ekins, Sean
Clark, Alex M
Sarker, Malabika
TB Mobile: a mobile app for anti-tuberculosis molecules with known targets
title TB Mobile: a mobile app for anti-tuberculosis molecules with known targets
title_full TB Mobile: a mobile app for anti-tuberculosis molecules with known targets
title_fullStr TB Mobile: a mobile app for anti-tuberculosis molecules with known targets
title_full_unstemmed TB Mobile: a mobile app for anti-tuberculosis molecules with known targets
title_short TB Mobile: a mobile app for anti-tuberculosis molecules with known targets
title_sort tb mobile: a mobile app for anti-tuberculosis molecules with known targets
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3616884/
https://www.ncbi.nlm.nih.gov/pubmed/23497706
http://dx.doi.org/10.1186/1758-2946-5-13
work_keys_str_mv AT ekinssean tbmobileamobileappforantituberculosismoleculeswithknowntargets
AT clarkalexm tbmobileamobileappforantituberculosismoleculeswithknowntargets
AT sarkermalabika tbmobileamobileappforantituberculosismoleculeswithknowntargets